Fig. 2From: Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials(a) Complete response, (b) complete control, and (c) total control.The bar graph shows the percentages of patients in whom chemotherapy-induced nausea and vomiting was controlled in the overall (0–120 h), acute (0–24 h), and delayed (24–120 h) periodsBack to article page